Improving The Detection Of African Swine Fever Virus Antibodies In Serum

Sep 05, 2022

African swine fever (ASF) is a highly infectious and fatal disease of pigs. Due to the complexity of the ASF virus (ASFV) and various clinical forms of the disease, a wide range of highly effective and robust sero-diagnostic assays are required.

The use of the most antigenic ASFV proteins is highly crucial to improving sero-diagnostic assays. Currently, only a few highly antigenic recombinant proteins have been tested and validated for use as reagents in ASF sero-diagnostic assays. So far, three ELISA kits based on the recombinant proteins P72, P30, and PP62 have been approved.

In a new study published in Biosafety and Health based on the recombinant P22 protein, a highly sensitive, specific, and rapid P22 monoclonal antibody-based blocking ELISA (mAb-bELISA) assay was developed to detect serum antibodies induced by genotype I and II ASFVs to detect ASFV antibodies. A total of 806 pig serum samples were tested to evaluate the performance of the diagnostic assay. The assay was able to detect ASFV antibodies as early as 9 days post-infection.

Click here to see more...

Video: Unveiling a Breakthrough Genetic Solution for Future-Proof, Sustainable Pork Production

Marcel Huijsmans, Global Marketing Director at Topigs Norsvin tells us about their new genetic solution R3silience that offers a solid alternative to how the industry can approach disease management.

R3silience delivers scientifically proven, naturally resilient pigs that thrive under disease pressure, enabling more predictable, sustainable production by reducing losses and sustaining growth under disease challenge.

R3silience pigs deliver higher survival, stronger overall performance, and healthier herds - reducing wean-to-finish mortality by up to 6 percentage points during multifactorial PRRS outbreak*.

R3silience pigs not only show higher survival, but also deliver superior growth, improving daily weight gain by up to 0.04lbs. per day under multifactorial PRRS outbreak.*

Pigs with enhanced resilience to both viral and bacterial diseases require fewer health interventions and up to 8% less antibiotic treatments from wean-to-finish*, supporting better animal welfare.

For more information visit https://topigsnorsvin.com/products/r3...